[Clinical evaluation of the effects of beta-adrenergic blocking in heart diseases, with special reference to disorders of rhythm and circulation].
D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002082:Butylamines / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy; D004562:Electrocardiography; D004983:Ethanolamines / Q000627:therapeutic use; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*
D002082:Butylamines; D004983:Ethanolamines; D009281:Naphthalenes; D013565:Sympatholytics; D011433:Propranolol
Valutazione clinica degli effetti del blocco beta-adrenergico nelle cardiopatie con particolare riguardo alle turbe del ritmo e della irrorazione.